Red flags / Dilution
SELLAS Life Sciences to sell 11.5 million shares at $13.00 in $150 million offering
SELLAS Life Sciences Group is offering 11,538,462 shares of common stock at a public offering price of $13.00 per share, for gross proceeds of about $150.0 million before underwriting discounts and expenses, with net proceeds to the company of about $141.0 million. The price is a discount to the $17.95 closing price on November 18, 2026, and the underwriters hold a 30-day option to buy up to 1,730,769 additional shares. Dilution from an offering of this size can weigh on existing holders' ownership and per-share value.
“We are offering 11,538,462 shares of our common stock.”
What the stock did
From the last close before the filing was public. Market cap now: $2.8B.
Prospectus supplement or shelf for new shares, including at-the-market programs. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.
Other flags on SLS
| Filed | Stock | Flag | What the filing says | Mkt cap | 5 days | 20 days |
|---|---|---|---|---|---|---|
| Nov 17, 4:14 PM ET | SLS SELLAS Life Sciences Group Inc. | Dilution ElevatedForm 424B5 | SELLAS Life Sciences files for $150 million common stock offering | $2.8B | - | - |